Exergaming Revolution in Dementia
About this study
This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.
- Condition
- Major Neurocognitive Disorder, Alzheimer Disease, Parkinson Disease, Lewy Body Dementia, Mixed Dementias
- Tested
- Exergaming on Dividat Senso, Usual Care
- Sponsor
- Eastern Switzerland University of Applied Sciences
Who can join
- Age
- Not specified
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 3
- Study condition: Major Neurocognitive Disorder, Alzheimer Disease, Parkinson Disease, Lewy Body Dementia, Mixed Dementias
- Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5)
- Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30
Exclusion 4
- MMSE \<5
- Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the American College of Sports Medicine
- Planned transfer to another facility within the next 3 months
- Acute behavioural problems
Where
1 site, 1 recruiting
Sonnweid AG
Wetzikon, Canton of Zurich, Switzerland
Contact
-
Eling de Bruin, Prof. Dr.
+41 58 257 14 11 eling.debruin@ost.ch
-
Andrea Hausheer
+41 58 257 14 77 andrea.hausheer@ost.ch
Potential match only. Final eligibility is determined by the study team.